-+ 0.00%
-+ 0.00%
-+ 0.00%

Inhibrx Biosciences Reports Q2 2025 Results: Revenue Jumps to $1.3M, Net Loss Hits $28.7M, EPS at -$1.85

Reuters·08/13/2025 20:06:08

Please log in to view news